PSA Today Dec 19: Drift on mixed messages / Mobile payment alliance to end / Astellas, Seattle Genetics FDA approval / Fujifilm adds Hitachi's imaging / Showa Denko + Hitachi Chem =?? / HCM and Komatsu shares, the dance – Nikkei -0.29%
Japan Market Comment by Pelham Smithers, Joel Scheiman, William Nestuk and Thao NguyenNikkei ¥23,864.85 (-¥69.58 / -0.29%); Topix ¥1,736.11 (-¥2.29/ -0.13%); ¥/$109.46
Tags: Hitachi (6501 JT), Mitsubishi Heavy Industries (7011 JT), Showa Denko (4004 JT), Hitachi Chemical (4217 JT), Isuzu (7202 JT), Shionogi (4507 JT), UMN Pharma (4585 JT), Astellas Pharma (4503 JT), Seattle Genetics (SGEN US), Eisai (4523 JT), NuFlare Technology (6256 JT), Toshiba (6502 JT), Hoya (7741 JT), SoftBank Corp (9984 JT), Uber (UBER US), Nintendo (7974 JT), LINE Corp (3938 JT), NTT DOCOMO (9437 JT), KDDI (9433 JT), Mercari (4385 JT), Z Holdings (4689 JT), Rakuten (4755 JT), Digital Garage (4819 JT), Takeda Pharmaceutical (4502 JT), Fujifilm Holdings (4901 JT), Canon (7751 JT), Mizuho Financial Group (8411 TSE), Hitachi Construction Machinery (6503 JT), Komatsu (6301 JT)
Main Points
• Tokyo drifts on mixed economic messages
• Mobile payment alliance ends
• Astellas, Seattle Genetics get US FDA approval for Padcev
• Showa Denko’s Scheme to Buy Hitachi Chemical
• Fujifilm to acquire Hitachi’s diagnostic imaging
• Hitachi divestiture fever lifts HCM over Komatsu yet again
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.